Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs

Michael Maes; Eugène Bosmans; Rakesh Ranjan; Eric Vandoolaeghe; Herbert Y. Meltzer; Marc De Ley; Raf Berghmans; Greet Stans; Roger Desnyder

doi:10.1016/0920-9964(96)00029-1

Back

Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs

Article 1996 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1995

Increased serum interleukin-1-receptor-antagonist concentrations in major depression

Michael Maes, Eric Vandoolaeghe, Rakesh Ranjan, Eugène Bosmans, Raf Bergmans, Roger Desnyder

Article1996

Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs

Michael Maes, Ingrid De Meester, Simon Scharpé, Roger Desnyder, Rakesh Ranjan, Herbert Y. Meltzer

Article1995

Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs

Michael Maes, Filip Goossens, Simon Scharpé, Joseph R. Calabrese, Roger Desnyder, Herbert Y. Meltzer

Article2008

Haplotypes of the interleukin-1 receptor antagonist gene, interleukin-1 receptor antagonist mRNA levels and the risk of myocardial infarction

Rick van Minkelen, Stephanie Bezzina Wettinger, Marieke C. Visser, Hans L. Vos, Pieter H. Reitsma, Frits R. Rosendaal, Rogier M. Bertina, Carine J.M. Doggen

Atherosclerosis

Article2000

Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission.

Marta Kubera, Günter Kenis, E. Bosmans, Agata Zięba, Dominika Dudek, Gabriel Nowak, Michael Maes